astemizole has been researched along with Drop Attack in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gowardman, J | 1 |
1 other study available for astemizole and Drop Attack
| Article | Year |
|---|---|
QT prolongation on the standard dose of astemizole.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Astemizole; Electrocardiography; Female; Histamine H1 | 1996 |